Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
basic toxicokinetics in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Data is from peer reviewed journal

Data source

Reference
Reference Type:
publication
Title:
Metabolism of Parabens (4-Hydroxybenzoic Acid Esters) by Hepatic Esterases and UDP Glucuronosyltransferases in Man
Author:
Suzanne Abbas, Jacques Magdalou, Helene greige-gerges et al
Year:
2010
Bibliographic source:
Drug Metab. Pharmacokinet. 25 (6): 568–577 (2010)

Materials and methods

Objective of study:
metabolism
Test guideline
Qualifier:
according to guideline
Guideline:
other:
Principles of method if other than guideline:
Details of guidelines not mentioned in the publication
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Benzyl 4-hydroxybenzoate
EC Number:
202-311-9
EC Name:
Benzyl 4-hydroxybenzoate
Cas Number:
94-18-8
Molecular formula:
C14H12O3
IUPAC Name:
benzyl 4-hydroxybenzoate
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder
Details on test material:
CAS No: 94-18-8
Chemical Name: Benzyl 4-hydroxybenzoate (Synonym: benzyl paraben)
Nature of chemical: Organic
Radiolabelling:
no

Test animals

Species:
other: Human liver microsomes (pool of 21 livers from men and women)
Strain:
not specified
Sex:
not specified
Details on test animals or test system and environmental conditions:
Not applicable considering in-vitro study

Administration / exposure

Details on exposure:
The hydrolysis and glucuronidation of benzyl paraben were investigated in human liver microsomes.
Calibration curves were constructed by plotting the paraben/standard paraben area ratio against the concentration of paraben in mg/mL, and the linear relationships were evaluated by regression analysis with the least-squares method. The equations were drawn from eight concentrations and the experiments were repeated six times. The lower limits of detection was 550 ng/ml for benzylparaben.
Duration and frequency of treatment / exposure:
24 hr
Doses / concentrations
Remarks:
Doses / Concentrations:
100 µg benzylparaben
No. of animals per sex per dose / concentration:
Not applicable considering in-vitro study
Control animals:
no

Results and discussion

Main ADME resultsopen allclose all
Type:
absorption
Results:
Details not available
Type:
distribution
Results:
Details not available
Type:
metabolism
Results:
The hydrolysis of parabens in human liver microsomes occurred more rapidly than in plasma, and the rate decreased as a function of the chain length. The hydrolysis rate followed first-order kinetics.
Type:
excretion
Results:
Not applicable

Metabolite characterisation studies

Metabolites identified:
yes
Details on metabolites:
benzylparaben-4 O-glucuronide.

Any other information on results incl. tables

Metabolism: The hydrolysis of parabens in human liver microsomes occurred more rapidly than in plasma, and the rate decreased as a function of the chain length. The hydrolysis rate followed first-order kinetics, thus allowing the determination of hydrolysis rate constants and half-lives. The benzylparaben was hydrolyzed at an intermediate rate, with a half-life of 43 min. The results indicated the formation of a benzylparaben-4 O-glucuronide.

Possible metabolic route of parabens in attached as a figure.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): low bioaccumulation potential based on study results
This study shows that parabens are extensively metabolized in human liver microsomes by the combined action of esterases and UGT [UDP-glucuronosyltransferase] (UGT) of families 1A and 2B. This active biotransformation is likely to prevent the accumulation of these molecules in man and thus prevent their possible toxicity.
Executive summary:

In an in-vitro study conducted with Benzyl 4-hydroxybenzoate (Synonym: benzyl paraben) using human liver microsomes,the hydrolysis of the paraben occurred more rapidly than in plasma. The hydrolysis rate followed first-order kinetics, thus allowing the determination of hydrolysis rate constants and half-lives. The benzyl paraben had a half-life of 43 min. Benzyl paraben is metabolized to benzylparaben-4 O-glucuronide.This active biotransformation is likely to prevent the accumulation of these molecules in man and thus prevent their possible toxicity.